Publication | Open Access
Long-term effectiveness and tolerability of galcanezumab in patients with migraine excluded from clinical trials: real world evidence of 1055 patients with 1 year follow-up from the Galca-Only registry
11
Citations
27
References
2023
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1